West Family Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

West Family Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$883K	Sell	63,757 -13,496	-17%	-$188K	0.31%	58
2025 Q4	$1.08M	Sell	77,253 -15,568	-17%	-$218K	0.25%	77
2025 Q3	$1.3M	Buy	92,821 +4,256	+5%	+$61.2K	0.29%	71
2025 Q2	$1.33M	Buy	88,565 +23,966	+37%	+$342K	0.35%	62
2025 Q1	$852K	Sell	64,599 -12,337	-16%	-$170K	0.32%	64
2024 Q4	$1.21M	Buy	76,936 +10,811	+16%	+$162K	0.42%	47
2024 Q3	$1.05M	Buy	66,125 +2,930	+5%	+$47.1K	0.36%	60
2024 Q2	$963K	Buy	63,195 +5,390	+9%	+$77.3K	0.29%	69
2024 Q1	$848K	Buy	57,805 +675	+1%	+$9.86K	0.26%	75
2023 Q4	$795K	Buy	57,130 +610	+1%	+$8.16K	0.27%	72
2023 Q3	$756K	Sell	56,520 -1,170	-2%	-$15.8K	0.26%	76
2023 Q2	$728K	Buy	+57,690	New	+$673K	0.28%	76
2023 Q1	–	Sell	-49,045	Closed	-$508K	–	257
2022 Q4	$508K	Sell	49,045 -3,240	-6%	-$35K	0.17%	105
2022 Q3	$547K	Buy	52,285 +5,470	+12%	+$58.3K	0.23%	91
2022 Q2	$519K	Buy	+46,815	New	+$509K	0.2%	91
2022 Q1	–	Sell	-40,960	Closed	-$536K	–	337
2021 Q4	$536K	Buy	+40,960	New	+$516K	0.15%	113
2021 Q3	–	Sell	-37,285	Closed	-$548K	–	380
2021 Q2	$548K	Buy	+37,285	New	+$521K	0.15%	120

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

West Family Investments's RDY Position: Q1 2026 in Review

West Family Investments reduced its Dr. Reddy's Laboratories (RDY) stake by 17% in Q1 2026, selling an estimated $188K and leaving 63,757 shares worth $883K. The position accounts for 0.31% of the portfolio, ranked #58.

West Family Investments first reported a position in RDY in Q2 2021 and has held it in 17 quarters since. The position peaked at $1.33M in Q2 2025. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

West Family Investments held 63,757 shares of Dr. Reddy's Laboratories worth $883K as of Q1 2026.
West Family Investments sold 13,496 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $188K.
Dr. Reddy's Laboratories made up 0.31% of West Family Investments's portfolio in Q1 2026, its #58 holding.
West Family Investments first reported a position in Dr. Reddy's Laboratories in Q2 2021 and has held it in 17 quarters since.
West Family Investments's Dr. Reddy's Laboratories position peaked at $1.33M in Q2 2025.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on West Family Investments's 13F filing for Q1 2026, filed 7 May 2026.